The Limited Times

Now you can see non-English news...

Oxford vaccine, 'robust data and no impact on timing'


The data from the Oxford-Irbm-AstraZeneca anti-Covid vaccine "are robust" and the additional studies started "will not impact on the expected timeframe". (HANDLE)

(ANSA) - ROME, NOVEMBER 27 - The data from the anti-CovidOxford-Irbm-AstraZeneca vaccine "are robust" and the supplementary studies started "will not impact on the expected times".

The next week the data will be published in a scientific journal and "soon", the time to complete the dossier, will be presented to the EMA.

Production of the vaccine candidate "continues" and the first doses will be available as soon as the vaccine is approved.

   ANSA learns this from company sources.


Source: ansa

All life articles on 2020-11-28

You may like

Life/Entertain 2020-11-28T19:39:59.370Z
News/Politics 2020-11-02T16:20:50.790Z

Trends 24h

Life/Entertain 2021-01-17T12:50:01.316Z
Life/Entertain 2021-01-17T07:50:01.519Z


© Communities 2019 - Privacy